Bulk Manufacturer of Controlled Substances Application: Cayman Chemical Company, 9217-9219 [2016-03854]
Download as PDF
<![CDATA[
mstockstill on DSK4VPTVN1PROD with NOTICES
Federal Register / Vol. 81, No. 36 / Wednesday, February 24, 2016 / Notices
and 36 CFR part 242 require that
persons engaged in taking fish, shellfish,
and wildlife on public lands in Alaska
for subsistence uses must apply for and
obtain a permit to do so and comply
with reporting provisions of that permit.
We use the following forms to collect
information from qualified rural
residents for subsistence harvest:
(1) FWS Form 3–2326 (Federal
Subsistence Hunt Application, Permit,
and Report).
(2) FWS Form 3–2327 (Designated
Hunter Permit Application, Permit, and
Report).
(3) FWS Form 3–2328 (Federal
Subsistence Fishing Application,
Permit, and Report).
(4) FWS Form 3–2378 (Designated
Fishing Permit Application, Permit, and
Report).
(5) FWS Form 3–2379 (Federal
Subsistence Customary Trade
Recordkeeping Form).
We use the information collected to
evaluate:
• Eligibility of applicant.
• Subsistence harvest success.
• Effectiveness of season lengths,
harvest quotas, and harvest restrictions.
• Hunting patterns and practices.
• Hunter use.
The Federal Subsistence Board uses
the harvest data, along with other
information, to set future season dates
and harvest limits for Federal
subsistence resource users. These
seasons and harvest limits are set to
meet the needs of subsistence users
without adversely impacting the health
of existing animal populations.
Also included in this ICR are three
forms associated with recruitment and
selection of members for regional
advisory councils.
(1) FWS Form 3–2321 (Federal
Subsistence Regional Advisory Council
Membership Application/Nomination).
(2) FWS Form 3–2322 (Regional
Advisory Council Candidate Interview).
(3) FWS Form 3–2323 (Regional
Advisory Council Reference/Key
Contact Interview).
The member selection process begins
with the information that we collect on
the application. Ten interagency review
panels interview all applicants and
nominees, their references, and regional
key contacts. These contacts are all
based on the information that the
applicant provides on the application
form. The information that we collect
through the application form and
subsequent interviews is the basis of the
Federal Subsistence Board’s
recommendations to the Secretaries of
the Interior and Agriculture for
appointment and reappointment of
council members.
VerDate Sep<11>2014
17:59 Feb 23, 2016
Jkt 238001
In addition to the above forms,
regulations at 50 CFR part 100 and 36
CFR part 242 contain requirements for
the collection of information. We collect
nonform information on:
(1) Repeal of Federal subsistence rules
and regulations (50 CFR 100.14 and 36
CFR 242.14).
(2) Proposed changes to Federal
subsistence regulations (50 CFR 100.18
and 36 CFR 242.18).
(3) Special action requests (50 CFR
100.19 and 36 CFR 242.19).
(4) Requests for reconsideration (50
CFR 100.20 and 36 CFR 242.20).
(5) Requests for permits and reports,
such as traditional religious/cultural/
educational permits, fishwheel permits,
fyke net permits, and under-ice permits
(50 CFR 100.25–27 and 36 CFR 242.25–
27).
Comments Received and Our Responses
Comments: On October 15, 2015, we
published in the Federal Register (80
FR 62091) a notice of our intent to
request that OMB renew approval for
this information collection. In that
notice, we solicited comments for 60
days, ending on December 14, 2015. We
did not receive any comments in
response to that notice.
Request for Public Comments
We again invite comments concerning
this information collection on:
• Whether or not the collection of
information is necessary, including
whether or not the information will
have practical utility;
• The accuracy of our estimate of the
burden for this collection of
information;
• Ways to enhance the quality, utility,
and clarity of the information to be
collected; and
• Ways to minimize the burden of the
collection of information on
respondents.
Comments that you submit in
response to this notice are a matter of
public record. Before including your
address, phone number, email address,
or other personal identifying
information in your comment, you
should be aware that your entire
comment, including your personal
identifying information, may be made
publicly available at any time. While
you can ask OMB and us in your
comment to withhold your personal
identifying information from public
review, we cannot guarantee that it will
be done.
PO 00000
Frm 00057
Fmt 4703
Sfmt 4703
9217
Dated: February 19, 2016.
Tina A. Campbell,
Chief, Division of Policy, Performance, and
Management Programs, U.S. Fish and Wildlife
Service.
[FR Doc. 2016–03819 Filed 2–23–16; 8:45 am]
BILLING CODE 4333–15–P
JUDICIAL CONFERENCE OF THE
UNITED STATES
Meeting of the Judicial Conference
Advisory; Committee on Rules of
Appellate Procedure
Advisory Committee on Rules
of Appellate Procedure, Judicial
Conference of the United States.
ACTION: Notice of open meeting.
AGENCY:
The Advisory Committee on
Rules of Appellate Procedure will hold
a meeting on April 5, 2016, which will
continue the morning of April 6, 2016,
if necessary. The meeting will be open
to public observation but not
participation. An agenda and supporting
materials will be posted at least 7 days
in advance of the meeting at: https://
www.uscourts.gov/rules-policies/
records-and-archives-rules-committees/
agenda-books.
DATES: April 5–6, 2016.
Time: 9:00 a.m. to 5:00 p.m.
ADDRESSES: Colorado Supreme Court, 2
East 14th Avenue, Conference Room
C4244, Denver, CO 80203.
FOR FURTHER INFORMATION CONTACT:
Rebecca A. Womeldorf, Rules
Committee Secretary, Rules Committee
Support Office, Administrative Office of
the United States Courts, Washington,
DC 20544, telephone (202) 502–1820.
SUMMARY:
Dated: February 17, 2016.
Rebecca A. Womeldorf,
Rules Committee Secretary.
[FR Doc. 2016–03865 Filed 2–23–16; 8:45 am]
BILLING CODE 2210–55–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Bulk Manufacturer of Controlled
Substances Application: Cayman
Chemical Company
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration in
DATES:
E:\FR\FM\24FEN1.SGM
24FEN1
9218
Federal Register / Vol. 81, No. 36 / Wednesday, February 24, 2016 / Notices
accordance with 21 CFR 1301.33(a) on
or before April 25, 2016.
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/ODW, 8701
Morrissette Drive, Springfield, Virginia
22152.
ADDRESSES:
The
Attorney General has delegated her
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Deputy Assistant
Administrator of the DEA Office of
Diversion Control (‘‘Deputy Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.33(a), this is notice that on August
24, 2015, Cayman Chemical Company,
1180 East Ellsworth Road, Ann Arbor,
Michigan 48108 applied to be registered
as a bulk manufacturer of the following
basic classes of controlled substances:
SUPPLEMENTARY INFORMATION:
mstockstill on DSK4VPTVN1PROD with NOTICES
Controlled substance
Schedule
3-Fluoro-N-methylcathinone
(3–
FMC) (1233).
Cathinone (1235) ..........................
Methcathinone (1237) ..................
4-Fluoro-N-methylcathinone
(4–
FMC) (1238).
Pentedrone
(amethylaminovalerophenone)
(1246).
Mephedrone
(4-Methyl-Nmethylcathinone) (1248).
4-Methyl-N-ethylcathinone
(4–
MEC) (1249).
Naphyrone (1258) ........................
N-Ethylamphetamine (1475) ........
N,N-Dimethylamphetamine (1480)
Aminorex (1585) ...........................
4-Methylaminorex (cis isomer)
(1590).
Gamma
Hydroxybutyric
Acid
(2010).
Methaqualone (2565) ...................
Mecloqualone (2572) ....................
JWH–250
(1-Pentyl-3-(2methoxyphenylacetyl)indole)
(6250).
SR–18 (Also known as RCS–8)
(1-Cyclohexylethyl-3-(2methoxyphenylacetyl)indole)
(7008).
VerDate Sep<11>2014
17:59 Feb 23, 2016
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
Jkt 238001
Controlled substance
5-Flouro-UR–144 and XLR11 [1(5-Fluoro-pentyl)1H-indol-3yl](2,2,3,3tetramethylcyclopropyl)methanone (7011).
AB–FUBINACA
(N-(1-amino-3methyl-1-oxobutan-2-yl)-1-(4fluorobenzyl)-1H-indazole-3carboxamide) (7012).
JWH–019
(1-Hexyl-3-(1-naphthoyl)indole) (7019).
AB–PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1Hindazole-3-carboxamide) (7023).
THJ–2201 [1-(5-fluoropentyl)-1Hindazol-3-yl](naphthalen-1yl)methanone (7024).
AB–CHMINACA
(N-(1-amino-3methyl-1-oxobutan-2-yl)-1(cyclohexylmethyl)-1H-indazole3-carboxamide (7031).
ADB–PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1pentyl-1H-indazole-3carboxamide) (7035).
APINACA and AKB48 N-(1Adamantyl)-1-pentyl-1H-indazole-3-carboxamide (7048).
JWH–081
(1-Pentyl-3-(1-(4methoxynaphthoyl)indole)
(7081).
SR–19 (Also known as RCS–4)
(1-Pentyl-3-[(4-methoxy)-benzoyl]indole (7104).
JWH–018 (also known as AM678)
(1-Pentyl-3-(1-naphthoyl)indole)
(7118).
JWH–122 (1-Pentyl-3-(4-methyl-1naphthoyl)indole) (7122).
UR–144
(1-Pentyl-1H-indol-3yl)(2,2,3,3tetramethylcyclopropyl)methanone (7144).
JWH–073
(1-Butyl-3-(1-naphthoyl)indole) (7173).
JWH–200
(1-[2-(4Morpholinyl)ethyl]-3-(1-naphthoyl)indole) (7200).
AM–2201 (1-(5-Fluoropentyl)-3-(1naphthoyl)indole) (7201).
JWH–203
(1-Pentyl-3-(2chlorophenylacetyl)indole)
(7203).
PB–22 (Quinolin-8-yl 1-pentyl-1Hindole-3-carboxylate) (7222).
5F–PB–22 (Quinolin-8-yl 1-(5fluoropentyl)-1H-indole-3carboxylate) (7225).
Alpha-ethyltryptamine (7249) .......
CP–47,497
(5-(1,1Dimethylheptyl)-2-[(1R,3S)-3hydroxycyclohexyl-phenol)
(7297).
CP–47,497 C8 Homologue (5(1,1-Dimethyloctyl)-2-[(1R,3S)3hydroxycyclohexyl-phenol)
(7298).
Lysergic acid diethylamide (7315)
2,5-Dimethoxy-4-(n)propylthiophenethylamine) (2C–
T–7) (7348).
Marihuana (7360) .........................
Tetrahydrocannabinols (7370) .....
Mescaline (7381) ..........................
PO 00000
Frm 00058
Fmt 4703
Sfmt 4703
Schedule
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
Controlled substance
2-(4-Ethylthio-2,5dimethoxyphenyl) ethanamine
(2C–T–2) (7385).
3,4,5-Trimethoxyamphetamine
(7390).
4-Bromo-2,5dimethoxyamphetamine (7391).
4-Bromo-2,5dimethoxyphenethylamine
(7392).
4-Methyl-2,5dimethoxyamphetamine (7395).
2,5-Dimethoxyamphetamine
(7396).
JWH–398 (1-Pentyl-3-(4-chloro-1naphthoyl)indole) (7398).
2,5-Dimethoxy-4ethylamphetamine (7399).
3,4-Methylenedioxyamphetamine
(7400).
5-Methoxy-3,4methylenedioxyamphetamine
(7401).
N-Hydroxy-3,4methylenedioxyamphetamine
(7402).
3,4-Methylenedioxy-Nethylamphetamine (7404).
3,4Methylenedioxymethamphetamine (7405).
4-Methoxyamphetamine (7411) ...
5-Methoxy-N–Ndimethyltryptamine (7431).
Alpha-methyltryptamine (7432) ....
Diethyltryptamine (7434) ..............
Dimethyltryptamine (7435) ...........
Psilocybin (7437) ..........................
Psilocyn (7438) .............................
5-Methoxy-N,Ndiisopropyltryptamine (7439).
N-Benzylpiperazine (7493) ...........
2-(2,5-Dimethoxy-4methylphenyl)ethanamine (2C–
D) (7508).
2-(2,5-Dimethoxy-4ethylphenyl)ethanamine (2C–E)
(7509).
2-(2,5Dimethoxyphenyl)ethanamine
(2C–H) (7517).
2-(4-Iodo-2,5dimethoxyphenyl)ethanamine
(2C–I) (7518).
2-(4-Chloro-2,5dimethoxyphenyl)ethanamine
(2C–C) (7519).
2-(2,5-Dimethoxy-4-nitrophenyl)ethanamine
(2C–N)
(7521).
2-(2,5-Dimethoxy-4-(n)propylphenyl)ethanamine (2C–
P) (7524).
2-(4-Isopropylthio)-2,5dimethoxyphenyl)ethanamine
(2C–T–4) (7532).
MDPV
(3,4Methylenedioxypyrovalerone)
(7535).
2-(4-bromo-2,5-dimethoxyphenyl)N-(2-methoxybenzyl)ethanamine
(25B–
NBOMe) (7536).
E:\FR\FM\24FEN1.SGM
24FEN1
Schedule
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
9219
Federal Register / Vol. 81, No. 36 / Wednesday, February 24, 2016 / Notices
Controlled substance
Schedule
mstockstill on DSK4VPTVN1PROD with NOTICES
2-(4-chloro-2,5-dimethoxyphenyl)N-(2-methoxybenzyl)ethanamine
(25C–
NBOMe) (7537).
2-(4-iodo-2,5-dimethoxyphenyl)-N(2-methoxybenzyl)ethanamine
(25I–NBOMe) (7538).
Methylone (3,4-Methylenedioxy-Nmethylcathinone) (7540).
Butylone (7541) ............................
Pentylone (7542) ..........................
alpha-pyrrolidinopentiophenone
(a-PVP) (7545).
alpha-pyrrolidinobutiophenone (aPBP) (7546).
AM–694 (1-(5-Fluoropentyl)-3-(2iodobenzoyl)indole) (7694).
Acetyldihydrocodeine (9051) ........
Benzylmorphine (9052) ................
Codeine-N-oxide (9053) ...............
Desomorphine (9055) ...................
Dihydromorphine (9145) ...............
Heroin (9200) ...............................
Morphine-N-oxide (9307) .............
Normorphine (9313) .....................
Tilidine (9750) ...............................
Acetyl
Fentanyl
(N-(1phenethylpiperidin-4-yl)-Nphenylacetamide) (9821).
Amphetamine (1100) ....................
Methamphetamine (1105) ............
Lisdexamfetamine (1205) .............
Methylphenidate (1724) ................
Amobarbital (2125) .......................
Pentobarbital (2270) .....................
Secobarbital (2315) ......................
Phencyclidine (7471) ....................
Phenylacetone (8501) ..................
Cocaine (9041) .............................
Codeine (9050) .............................
Dihydrocodeine (9120) .................
Oxycodone (9143) ........................
Hydromorphone (9150) ................
Ecgonine (9180) ...........................
Ethylmorphine (9190) ...................
Hydrocodone (9193) .....................
Levomethorphan (9210) ...............
Levorphanol (9220) ......................
Meperidine (9230) ........................
Meperidine intermediate-B (9233)
Methadone (9250) ........................
Dextropropoxyphene, bulk.
(non-dosage forms) (9273) ..........
Morphine (9300) ...........................
Thebaine (9333) ...........................
Oxymorphone (9652) ...................
Sufentanil (9740) ..........................
Tapentadol (9780) ........................
Fentanyl (9801) ............................
I
17:59 Feb 23, 2016
Controlled substance
[FR Doc. 2016–03854 Filed 2–23–16; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
I
Drug Enforcement Administration
I
I
I
[Docket No. DEA–392]
I
Bulk Manufacturer of Controlled
Substances Application: Janssen
Pharmaceutical, Inc.
I
ACTION:
I
I
I
I
I
I
I
I
I
I
DATES:
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
Jkt 238001
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration in
accordance with 21 CFR 1301.33(a) on
or before April 25, 2016
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/ODW, 8701
Morrissette Drive, Springfield, Virginia
22152.
SUPPLEMENTARY INFORMATION: The
Attorney General has delegated her
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Deputy Assistant
Administrator of the DEA Office of
Diversion Control (‘‘Deputy Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.33(a), this is notice that on
November 12, 2015, Janssen
Pharmaceutical, Inc., 1440 Olympic
Drive, Athens, Georgia 30601 applied to
be registered as a bulk manufacturer of
the following basic classes of controlled
substances:
Methylphenidate (1724) ................
Oxycodone (9143) ........................
Hydromorphone (9150) ................
Hydrocodone (9193) .....................
Oripavine (9330) ...........................
Thebaine (9333) ...........................
Oxymorphone (9652) ...................
PO 00000
Frm 00059
Fmt 4703
Sfmt 4703
II
II
Dated: February 16, 2016.
Louis J. Milione,
Deputy Assistant Administrator.
[FR Doc. 2016–03852 Filed 2–23–16; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Notice of application.
Controlled substance
Tapentadol (9780) ........................
Fentanyl (9801) ............................
Schedule
The company plans to manufacture
the above-listed controlled substances
in bulk for distribution to its customers.
I
The company plans to manufacture
reference standards for distribution to
their research and forensics customers.
In reference to drug codes 7360
(marihuana) and 7370
(tetrahydrocannabinols), the company
plans to bulk manufacture these drugs
as synthetic. No other activities for these
drug codes are authorized for this
registration.
VerDate Sep<11>2014
Dated: February 16, 2016.
Louis J. Milione,
Deputy Assistant Administrator.
Schedule
II
II
II
II
II
II
II
Drug Enforcement Administration
[Docket No. DEA–392]
Manufacturer of Controlled
Substances Registration: Cedarburg
Pharmaceuticals, Inc.
ACTION:
Notice of registration.
Cedarburg Pharmaceuticals,
Inc. applied to be registered as a
manufacturer of certain basic classes of
controlled substances. The Drug
Enforcement Administration (DEA)
grants Cedarburg Pharmaceuticals, Inc.
registration as a manufacturer of those
controlled substances.
SUPPLEMENTARY INFORMATION: By notice
dated September 16, 2015, and
published in the Federal Register on
September 23, 2015, 80 FR 57390,
Cedarburg Pharmaceuticals, Inc., 870
Badger Circle, Grafton, Wisconsin 53024
applied to be registered as a
manufacturer of certain basic classes of
controlled substances. No comments or
objections were submitted for this
notice.
The DEA has considered the factors in
21 U.S.C. 823(a) and determined that
the registration of Cedarburg
Pharmaceuticals, Inc. to manufacture
the basic classes of controlled
substances is consistent with the public
interest and with United States
obligations under international treaties,
conventions, or protocols in effect on
May 1, 1971. The DEA investigated the
company’s maintenance of effective
controls against diversion by inspecting
and testing the company’s physical
security systems, verifying the
company’s compliance with state and
local laws, and reviewing the company’s
background and history.
Therefore, pursuant to 21 U.S.C.
823(a), and in accordance with 21 CFR
1301.33, the above-named company is
granted registration as a bulk
manufacturer of the following basic
classes of controlled substances:
SUMMARY:
E:\FR\FM\24FEN1.SGM
24FEN1
]]>Agencies
[Federal Register Volume 81, Number 36 (Wednesday, February 24, 2016)]
[Notices]
[Pages 9217-9219]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-03854]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Bulk Manufacturer of Controlled Substances Application: Cayman
Chemical Company
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration in
[[Page 9218]]
accordance with 21 CFR 1301.33(a) on or before April 25, 2016.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/ODW,
8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The Attorney General has delegated her
authority under the Controlled Substances Act to the Administrator of
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority
to exercise all necessary functions with respect to the promulgation
and implementation of 21 CFR part 1301, incident to the registration of
manufacturers, distributors, dispensers, importers, and exporters of
controlled substances (other than final orders in connection with
suspension, denial, or revocation of registration) has been redelegated
to the Deputy Assistant Administrator of the DEA Office of Diversion
Control (``Deputy Assistant Administrator'') pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR 1301.33(a), this is notice that on August
24, 2015, Cayman Chemical Company, 1180 East Ellsworth Road, Ann Arbor,
Michigan 48108 applied to be registered as a bulk manufacturer of the
following basic classes of controlled substances:
------------------------------------------------------------------------
Controlled substance Schedule
------------------------------------------------------------------------
3-Fluoro-N-methylcathinone (3-FMC) (1233).. I
Cathinone (1235)........................... I
Methcathinone (1237)....................... I
4-Fluoro-N-methylcathinone (4-FMC) (1238).. I
Pentedrone ([alpha]- I
methylaminovalerophenone) (1246).
Mephedrone (4-Methyl-N-methylcathinone) I
(1248).
4-Methyl-N-ethylcathinone (4-MEC) (1249)... I
Naphyrone (1258)........................... I
N-Ethylamphetamine (1475).................. I
N,N-Dimethylamphetamine (1480)............. I
Aminorex (1585)............................ I
4-Methylaminorex (cis isomer) (1590)....... I
Gamma Hydroxybutyric Acid (2010)........... I
Methaqualone (2565)........................ I
Mecloqualone (2572)........................ I
JWH-250 (1-Pentyl-3-(2- I
methoxyphenylacetyl)indole) (6250).
SR-18 (Also known as RCS-8) (1- I
Cyclohexylethyl-3-(2-
methoxyphenylacetyl)indole) (7008).
5-Flouro-UR-144 and XLR11 [1-(5-Fluoro- I
pentyl)1H-indol-3-yl](2,2,3,3-
tetramethylcyclopropyl)methanone (7011).
AB-FUBINACA (N-(1-amino-3-methyl-1-oxobutan- I
2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-
carboxamide) (7012).
JWH-019 (1-Hexyl-3-(1-naphthoyl)indole) I
(7019).
AB-PINACA (N-(1-amino-3-methyl-1-oxobutan-2- I
yl)-1-pentyl-1H-indazole-3-carboxamide)
(7023).
THJ-2201 [1-(5-fluoropentyl)-1H-indazol-3- I
yl](naphthalen-1-yl)methanone (7024).
AB-CHMINACA (N-(1-amino-3-methyl-1-oxobutan- I
2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-
carboxamide (7031).
ADB-PINACA (N-(1-amino-3,3-dimethyl-1- I
oxobutan-2-yl)-1-pentyl-1H-indazole-3-
carboxamide) (7035).
APINACA and AKB48 N-(1-Adamantyl)-1-pentyl- I
1H-indazole-3-carboxamide (7048).
JWH-081 (1-Pentyl-3-(1-(4- I
methoxynaphthoyl)indole) (7081).
SR-19 (Also known as RCS-4) (1-Pentyl-3-[(4- I
methoxy)-benzoyl]indole (7104).
JWH-018 (also known as AM678) (1-Pentyl-3- I
(1-naphthoyl)indole) (7118).
JWH-122 (1-Pentyl-3-(4-methyl-1- I
naphthoyl)indole) (7122).
UR-144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3- I
tetramethylcyclopropyl)methanone (7144).
JWH-073 (1-Butyl-3-(1-naphthoyl)indole) I
(7173).
JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1- I
naphthoyl)indole) (7200).
AM-2201 (1-(5-Fluoropentyl)-3-(1- I
naphthoyl)indole) (7201).
JWH-203 (1-Pentyl-3-(2- I
chlorophenylacetyl)indole) (7203).
PB-22 (Quinolin-8-yl 1-pentyl-1H-indole-3- I
carboxylate) (7222).
5F-PB-22 (Quinolin-8-yl 1-(5-fluoropentyl)- I
1H-indole-3-carboxylate) (7225).
Alpha-ethyltryptamine (7249)............... I
CP-47,497 (5-(1,1-Dimethylheptyl)-2- I
[(1R,3S)-3-hydroxycyclohexyl-phenol)
(7297).
CP-47,497 C8 Homologue (5-(1,1- I
Dimethyloctyl)-2-[(1R,3S)3-
hydroxycyclohexyl-phenol) (7298).
Lysergic acid diethylamide (7315).......... I
2,5-Dimethoxy-4-(n)- I
propylthiophenethylamine) (2C-T-7) (7348).
Marihuana (7360)........................... I
Tetrahydrocannabinols (7370)............... I
Mescaline (7381)........................... I
2-(4-Ethylthio-2,5-dimethoxyphenyl) I
ethanamine (2C-T-2) (7385).
3,4,5-Trimethoxyamphetamine (7390)......... I
4-Bromo-2,5-dimethoxyamphetamine (7391).... I
4-Bromo-2,5-dimethoxyphenethylamine (7392). I
4-Methyl-2,5-dimethoxyamphetamine (7395)... I
2,5-Dimethoxyamphetamine (7396)............ I
JWH-398 (1-Pentyl-3-(4-chloro-1- I
naphthoyl)indole) (7398).
2,5-Dimethoxy-4-ethylamphetamine (7399).... I
3,4-Methylenedioxyamphetamine (7400)....... I
5-Methoxy-3,4-methylenedioxyamphetamine I
(7401).
N-Hydroxy-3,4-methylenedioxyamphetamine I
(7402).
3,4-Methylenedioxy-N-ethylamphetamine I
(7404).
3,4-Methylenedioxymethamphetamine (7405)... I
4-Methoxyamphetamine (7411)................ I
5-Methoxy-N-N-dimethyltryptamine (7431).... I
Alpha-methyltryptamine (7432).............. I
Diethyltryptamine (7434)................... I
Dimethyltryptamine (7435).................. I
Psilocybin (7437).......................... I
Psilocyn (7438)............................ I
5-Methoxy-N,N-diisopropyltryptamine (7439). I
N-Benzylpiperazine (7493).................. I
2-(2,5-Dimethoxy-4-methylphenyl)ethanamine I
(2C-D) (7508).
2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine I
(2C-E) (7509).
2-(2,5-Dimethoxyphenyl)ethanamine (2C-H) I
(7517).
2-(4-Iodo-2,5-dimethoxyphenyl)ethanamine I
(2C-I) (7518).
2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine I
(2C-C) (7519).
2-(2,5-Dimethoxy-4-nitro-phenyl)ethanamine I
(2C-N) (7521).
2-(2,5-Dimethoxy-4-(n)- I
propylphenyl)ethanamine (2C-P) (7524).
2-(4-Isopropylthio)-2,5- I
dimethoxyphenyl)ethanamine (2C-T-4) (7532).
MDPV (3,4-Methylenedioxypyrovalerone) I
(7535).
2-(4-bromo-2,5-dimethoxyphenyl)-N-(2- I
methoxybenzyl)ethanamine (25B-NBOMe)
(7536).
[[Page 9219]]
2-(4-chloro-2,5-dimethoxyphenyl)-N-(2- I
methoxybenzyl)ethanamine (25C-NBOMe)
(7537).
2-(4-iodo-2,5-dimethoxyphenyl)-N-(2- I
methoxybenzyl)ethanamine (25I-NBOMe)
(7538).
Methylone (3,4-Methylenedioxy-N- I
methylcathinone) (7540).
Butylone (7541)............................ I
Pentylone (7542)........................... I
alpha-pyrrolidinopentiophenone ([alpha]- I
PVP) (7545).
alpha-pyrrolidinobutiophenone ([alpha]-PBP) I
(7546).
AM-694 (1-(5-Fluoropentyl)-3-(2- I
iodobenzoyl)indole) (7694).
Acetyldihydrocodeine (9051)................ I
Benzylmorphine (9052)...................... I
Codeine-N-oxide (9053)..................... I
Desomorphine (9055)........................ I
Dihydromorphine (9145)..................... I
Heroin (9200).............................. I
Morphine-N-oxide (9307).................... I
Normorphine (9313)......................... I
Tilidine (9750)............................ I
Acetyl Fentanyl (N-(1-phenethylpiperidin-4- I
yl)-N-phenylacetamide) (9821).
Amphetamine (1100)......................... II
Methamphetamine (1105)..................... II
Lisdexamfetamine (1205).................... II
Methylphenidate (1724)..................... II
Amobarbital (2125)......................... II
Pentobarbital (2270)....................... II
Secobarbital (2315)........................ II
Phencyclidine (7471)....................... II
Phenylacetone (8501)....................... II
Cocaine (9041)............................. II
Codeine (9050)............................. II
Dihydrocodeine (9120)...................... II
Oxycodone (9143)........................... II
Hydromorphone (9150)....................... II
Ecgonine (9180)............................ II
Ethylmorphine (9190)....................... II
Hydrocodone (9193)......................... II
Levomethorphan (9210)...................... II
Levorphanol (9220)......................... II
Meperidine (9230).......................... II
Meperidine intermediate-B (9233)........... II
Methadone (9250)........................... II
Dextropropoxyphene, bulk...................
(non-dosage forms) (9273).................. II
Morphine (9300)............................ II
Thebaine (9333)............................ II
Oxymorphone (9652)......................... II
Sufentanil (9740).......................... II
Tapentadol (9780).......................... II
Fentanyl (9801)............................ II
------------------------------------------------------------------------
The company plans to manufacture reference standards for
distribution to their research and forensics customers.
In reference to drug codes 7360 (marihuana) and 7370
(tetrahydrocannabinols), the company plans to bulk manufacture these
drugs as synthetic. No other activities for these drug codes are
authorized for this registration.
Dated: February 16, 2016.
Louis J. Milione,
Deputy Assistant Administrator.
[FR Doc. 2016-03854 Filed 2-23-16; 8:45 am]
BILLING CODE 4410-09-P
